title: Decreasing initial hospitalization of the cyclosporine-treated renal allograft recipient is safe.
authors.affiliation: Department of Surgery, Harbor/UCLA Medical Center, Torrance 90509.
authors.forename: M A
authors.initials: MA
authors.lastname: Koyle
authors.forename: M
authors.initials: M
authors.lastname: Rosen
authors.forename: M B
authors.initials: MB
authors.lastname: Sender
authors.forename: J
authors.initials: J
authors.lastname: Rajfer
authors.forename: R J
authors.initials: RJ
authors.lastname: Glassock
authors.forename: H J
authors.initials: HJ
authors.lastname: Ward
mesh_terms: D003365:Costs and Cost Analysis; D003524:Cyclosporins / Q000627:therapeutic use*; D006760:Hospitalization / Q000191:economics*; D006801:Humans; D007165:Immunosuppression Therapy / Q000191:economics; D016030:Kidney Transplantation; D011182:Postoperative Care; D013997:Time Factors
chemical_list: D003524:Cyclosporins